A $6.7 million grant to fight hidden enemy
In an effort to combat metastatic breast cancer, the U.S. Department of Defense has jointly awarded a $6.7 million grant to Huntsman Cancer Institute (HCI) at the University of Utah, and the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.
With this new funding, HCI will focus on the biology of an important cellular pathway in metastatic breast cancer, while TGen will focus on drug development and supervise clinical trials to test those drugs.
“This is a critical unmet medical need. Cancer that has spread to the bone can cause unbearable pain for these patients,” said Jeffrey Trent, PhD, TGen President and Research Director. “For the first time, this team’s novel approach will seek to uncover this hidden cancer and enlist an immune response while at the same time preventing further damage to skeletal structures.”
Read the full story on the Newswise site.
PLEASE DONATE TODAY
Second Hope is run purely by volunteers, meaning that all donations received go to fulfil our charitable aims and objectives, not to pay salaries or expensive overheads